CG PHARMACEUTICALS
Live / Applied — Fifth extension granted (statement of use) (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 16 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97270447
- Mark type
- Stylized text
- Filed
- 16 Feb 2022
- Published for opposition
- 08 Aug 2023
- Attorney of record
- Chang Sik Lim
Goods and services
- Class 005 — Pharmaceuticals: biopharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; biologic preparations for the treatment of cancer; biologic preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations and substances for use in oncology treatment; pharmaceuticals for the treatment of cancer; prescription pharmaceuticals for treatment of diseases and disorders, namely, cancer and chronic diseases
- Class 041 — Education and entertainment services: Educational services, namely, conducting seminars regarding the use of prescription pharmaceutical products for medical disorders and dissemination of materials in connection therewith; providing motivational and educational speakers featuring information regarding medical disorders; conducting educational seminars in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products and dissemination of materials in connection therewith; educational services, namely, conducting classes, seminars, conferences or workshops in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products
- Class 044 — Medical, beauty and agricultural services: Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; Providing information regarding medical conditions; medical information services; providing medical information regarding testing, diagnosis, and treatment of diseases; providing medical information to patients regarding disease management and medication
Owner
- CG Pharmaceuticals, Inc, Orinda, CA, US
- CG Pharmaceuticals, Inc, Orinda, CA, US
Prosecution history
- 30 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2026 — SOU EXTENSION 5 GRANTED
- 30 Mar 2026 — SOU EXTENSION 5 FILED
- 27 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2025 — SOU EXTENSION 4 GRANTED
- 03 Oct 2025 — SOU EXTENSION 4 FILED
- 03 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2025 — SOU EXTENSION 3 GRANTED
- 01 Apr 2025 — SOU EXTENSION 3 FILED
- 18 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2024 — SOU EXTENSION 2 GRANTED